FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3011344476> ?p ?o ?g. }

• W3011344476 abstract "Abstract Background The current study aimed to evaluate the outcomes of patients with unresectable non-metastatic locally advanced pancreatic adenocarcinoma (LAPA) who did not benefit from resection considering the treatment strategy in the clinical settings. Methods Between 2010 and 2017, a total of 234 patients underwent induction chemotherapy for LAPA that could not be treated with surgery. After oncologic restaging, continuous chemotherapy or chemoradiation (CRT) was decided for patients without metastatic disease. The Kaplan–Meier method was used to determine overall survival (OS), and the Wilcoxon test to compare survival curves. Multivariate analysis was performed using the stepwise logistic regression method. Results FOLFIRINOX was the most common induction regimen (168 patients, 72%), with a median of 6 chemotherapy cycles and resulted in higher OS, compared to gemcitabine (19 vs. 16 months, hazard ratio (HR) = 1.2, 95% confidence interval: 0.86–1.6, P = .03). However, no difference was observed after adjusting for age (≤75 years) and performance status score (0–1). At restaging, 187 patients (80%) had non-metastatic disease: CRT was administered to 126 patients (67%) while chemotherapy was continued in 61 (33%). Patients who received CRT had characteristics comparable to those who continued with chemotherapy, with similar OS. They also had longer progression-free survival (median 13.3 vs. 9.6 months, HR = 1.38, 95% confidence interval: 1–1.9, P < .01) and limited short-term treatment-related toxicity. Conclusions The median survival of patients who could not undergo surgery was 19 months. Hence, CRT should not be eliminated as a treatment option and may be useful as a part of optimised sequential chemotherapy for both local and metastatic disease." @default.
• W3011344476 created "2020-03-23" @default.
• W3011344476 creator A5001651792 @default.
• W3011344476 creator A5040339716 @default.
• W3011344476 creator A5049257648 @default.
• W3011344476 creator A5055027274 @default.
• W3011344476 creator A5058171637 @default.
• W3011344476 creator A5059444864 @default.
• W3011344476 creator A5060159302 @default.
• W3011344476 creator A5076298509 @default.
• W3011344476 creator A5081081344 @default.
• W3011344476 creator A5082710196 @default.
• W3011344476 date "2020-03-12" @default.
• W3011344476 modified "2023-09-27" @default.
• W3011344476 title "Outcomes of patients with initially locally advanced pancreatic adenocarcinoma who did not benefit from resection: a prospective cohort study" @default.
• W3011344476 cites W1855728269 @default.
• W3011344476 cites W1995566427 @default.
• W3011344476 cites W2002114962 @default.
• W3011344476 cites W2005919713 @default.
• W3011344476 cites W2019214567 @default.
• W3011344476 cites W2037608659 @default.
• W3011344476 cites W2054616071 @default.
• W3011344476 cites W2097642908 @default.
• W3011344476 cites W2115663098 @default.
• W3011344476 cites W2118797060 @default.
• W3011344476 cites W2151253787 @default.
• W3011344476 cites W2162745988 @default.
• W3011344476 cites W2346921980 @default.
• W3011344476 cites W2465801062 @default.
• W3011344476 cites W2573113919 @default.
• W3011344476 cites W2587310769 @default.
• W3011344476 cites W2737789729 @default.
• W3011344476 cites W2743061229 @default.
• W3011344476 cites W2761072972 @default.
• W3011344476 cites W2770835903 @default.
• W3011344476 cites W2792655625 @default.
• W3011344476 cites W2883965363 @default.
• W3011344476 cites W2885803071 @default.
• W3011344476 cites W2889687464 @default.
• W3011344476 cites W2890275489 @default.
• W3011344476 cites W2899311685 @default.
• W3011344476 cites W2926499479 @default.
• W3011344476 cites W2948239024 @default.
• W3011344476 cites W2948795598 @default.
• W3011344476 cites W2948917476 @default.
• W3011344476 cites W2954531955 @default.
• W3011344476 cites W2971905351 @default.
• W3011344476 cites W2989955432 @default.
• W3011344476 doi "https://doi.org/10.1186/s12885-020-6690-1" @default.
• W3011344476 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7068994" @default.
• W3011344476 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32164564" @default.
• W3011344476 hasPublicationYear "2020" @default.
• W3011344476 type Work @default.
• W3011344476 sameAs 3011344476 @default.
• W3011344476 citedByCount "12" @default.
• W3011344476 countsByYear W30113444762020 @default.
• W3011344476 countsByYear W30113444762021 @default.
• W3011344476 countsByYear W30113444762022 @default.
• W3011344476 countsByYear W30113444762023 @default.
• W3011344476 crossrefType "journal-article" @default.
• W3011344476 hasAuthorship W3011344476A5001651792 @default.
• W3011344476 hasAuthorship W3011344476A5040339716 @default.
• W3011344476 hasAuthorship W3011344476A5049257648 @default.
• W3011344476 hasAuthorship W3011344476A5055027274 @default.
• W3011344476 hasAuthorship W3011344476A5058171637 @default.
• W3011344476 hasAuthorship W3011344476A5059444864 @default.
• W3011344476 hasAuthorship W3011344476A5060159302 @default.
• W3011344476 hasAuthorship W3011344476A5076298509 @default.
• W3011344476 hasAuthorship W3011344476A5081081344 @default.
• W3011344476 hasAuthorship W3011344476A5082710196 @default.
• W3011344476 hasBestOaLocation W30113444761 @default.
• W3011344476 hasConcept C121608353 @default.
• W3011344476 hasConcept C126322002 @default.
• W3011344476 hasConcept C141071460 @default.
• W3011344476 hasConcept C143998085 @default.
• W3011344476 hasConcept C188816634 @default.
• W3011344476 hasConcept C207103383 @default.
• W3011344476 hasConcept C2776611710 @default.
• W3011344476 hasConcept C2776694085 @default.
• W3011344476 hasConcept C2777148230 @default.
• W3011344476 hasConcept C2780258809 @default.
• W3011344476 hasConcept C2780962732 @default.
• W3011344476 hasConcept C2781413609 @default.
• W3011344476 hasConcept C44249647 @default.
• W3011344476 hasConcept C526805850 @default.
• W3011344476 hasConcept C71924100 @default.
• W3011344476 hasConceptScore W3011344476C121608353 @default.
• W3011344476 hasConceptScore W3011344476C126322002 @default.
• W3011344476 hasConceptScore W3011344476C141071460 @default.
• W3011344476 hasConceptScore W3011344476C143998085 @default.
• W3011344476 hasConceptScore W3011344476C188816634 @default.
• W3011344476 hasConceptScore W3011344476C207103383 @default.
• W3011344476 hasConceptScore W3011344476C2776611710 @default.
• W3011344476 hasConceptScore W3011344476C2776694085 @default.
• W3011344476 hasConceptScore W3011344476C2777148230 @default.
• W3011344476 hasConceptScore W3011344476C2780258809 @default.
• W3011344476 hasConceptScore W3011344476C2780962732 @default.
• W3011344476 hasConceptScore W3011344476C2781413609 @default.
• W3011344476 hasConceptScore W3011344476C44249647 @default.
• W3011344476 hasConceptScore W3011344476C526805850 @default.

• next